233 related articles for article (PubMed ID: 27621046)
1. Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study.
Pocius KD; Bartz D; Maurer R; Stenquist A; Fortin J; Goldberg AB
Contraception; 2017 Mar; 95(3):263-268. PubMed ID: 27621046
[TBL] [Abstract][Full Text] [Related]
2. Mifepristone and misoprostol for early abortion when no gestational sac is present.
Schaff EA; Fielding SL; Eisinger S; Stadalius L
Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464
[TBL] [Abstract][Full Text] [Related]
3. Early serum human chorionic gonadotropin (hCG) trends after medication abortion.
Pocius KD; Maurer R; Fortin J; Goldberg AB; Bartz D
Contraception; 2015 Jun; 91(6):503-6. PubMed ID: 25765358
[TBL] [Abstract][Full Text] [Related]
4. Change in serum beta-human chorionic gonadotropin after abortion with methotrexate and misoprostol.
Creinin MD
Am J Obstet Gynecol; 1996 Feb; 174(2):776-8. PubMed ID: 8623820
[TBL] [Abstract][Full Text] [Related]
5. Trend of serum beta-human chorionic gonadotropin levels after medical abortion in the early first trimester of pregnancy.
Choobun T; Maneeon R
J Obstet Gynaecol Res; 2023 Jan; 49(1):103-108. PubMed ID: 36184565
[TBL] [Abstract][Full Text] [Related]
6. The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy.
Honkanen H; Ranta S; Ylikorkala O; Heikinheimo O
Hum Reprod; 2002 Sep; 17(9):2315-9. PubMed ID: 12202418
[TBL] [Abstract][Full Text] [Related]
7. Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness.
Parashar P; Iversen OE; Midbøe G; Myking O; Bjørge L
Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):366-71. PubMed ID: 17853164
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate and misoprostol for early abortion: a multicenter trial. I. Safety and efficacy.
Creinin MD; Vittinghoff E; Keder L; Darney PD; Tiller G
Contraception; 1996 Jun; 53(6):321-7. PubMed ID: 8773418
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate and misoprostol used alone or in combination for early abortion.
Ozeren M; Bilekli C; Aydemir V; Bozkaya H
Contraception; 1999 Jun; 59(6):389-94. PubMed ID: 10518234
[TBL] [Abstract][Full Text] [Related]
10. Concurrent use of mifepristone and misoprostol for early medical abortion.
Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
[TBL] [Abstract][Full Text] [Related]
11. Monitoring medical abortion using mifepristone/misoprostol combination with ultrasonogram and serum human chorionic gonadotropin.
Chou SY; Chen CY; Chiang HK; Chow PK; Wang CC; Hsu CS
Taiwan J Obstet Gynecol; 2006 Mar; 45(1):48-52. PubMed ID: 17272208
[TBL] [Abstract][Full Text] [Related]
12. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
13. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
[TBL] [Abstract][Full Text] [Related]
14. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
Chawdhary R; Rana A; Pradhan N
J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.
Blum J; Sheldon WR; Ngoc NT; Winikoff B; Nga NT; Martin R; Van Thanh L; Blumenthal PD
Contraception; 2016 Aug; 94(2):115-21. PubMed ID: 27067706
[TBL] [Abstract][Full Text] [Related]
16. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
Guest J; Chien PF; Thomson MA; Kosseim ML
BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
Murthy AS; Creinin MD; Harwood B; Schreiber C
Contraception; 2005 May; 71(5):333-6. PubMed ID: 15854632
[TBL] [Abstract][Full Text] [Related]
18. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Ashok PW; Flett GM; Templeton A
Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous use of mifepristone and misoprostol for early pregnancy termination.
Li YT; Hsieh JC; Hou GQ; Chen TH; Chu YC; Lin TC; Kuan LC; Lin M; Tang HH; Kuo TC
Taiwan J Obstet Gynecol; 2011 Mar; 50(1):11-4. PubMed ID: 21482367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
